حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
AddLife AB (publ)
0REZAddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden. Address: Brunkebergstorg 5, Stockholm, Sweden, 103 62
Analytics
سعر الهدف في وول ستريت
1 803.87 SEKنسبة السعر إلى الأرباح
141.4433العائد الربحي
0.36 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية 0REZ
تحليلات الأرباح 0REZ
نمو الأرباح على مدى 5 سنوات
–النمو المستمر
2 سنينمعدل الدفع 5 سنوات في المتوسط
33 %تاريخ الأرباح 0REZ
تقييم الأسهم 0REZ
المالية 0REZ
نتائج | 2019 | ديناميات |